Stay updated on GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial

Sign up to get notified when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page history shows a new Revision: v3.3.3 and removal of the HHS Vulnerability Disclosure link in the footer. The core study content and status appear unchanged.
    Difference
    0.2%
    Check dated 2025-12-22T00:54:38.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The study record versions list now shows Revision: v3.3.2 and removes Revision: v3.3.1, reflecting a small history update.
    Difference
    0.1%
    Check dated 2025-11-30T07:20:05.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    A new revision entry v3.3.1 is added to the study record history and v3.2.0 is removed from the list.
    Difference
    0.1%
    Check dated 2025-11-23T08:17:50.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The notice about government funding and operating status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.8%
    Check dated 2025-11-16T07:01:31.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Version 2 updates Study Status, Sponsor/Collaborators, and Contacts/Locations. Version 3 updates Recruitment Status, Study Status, Study Design, and Contacts/Locations.
    Difference
    0.1%
    Check dated 2025-11-02T00:39:03.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Added a government funding notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates current operating status and references official sources.
    Difference
    13%
    Check dated 2025-10-04T12:13:42.000Z thumbnail image

Stay in the know with updates to GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GM-CLAG in Relapsed/Refractory FLT3-mutated AML Clinical Trial page.